Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2022 PharmSci 360 Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
Nishant Sawant, Ph.D.
Alexion AstraZeneca Rare Disease
Poster(s):
(T1330-04-19) Developability Assessment as an Early De-risking Tool for Biopharmaceuticals: Case Study with Fusion-Proteins
Tuesday, October 18, 2022
1:30 PM – 2:30 PM
ET
